LDLR and atherosclerosis: Our results suggest that while L4F can markedly reduce adipocyte inflammation in vitro similar to HDL, this does not carry through to improvements in inflammation, glucose tolerance, or atherosclerosis in Ldlr-/—male mice fed the HFHSC diet using an LF4 dose of 100 μg/day/mouse.